CD123 Redirected Autologous T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123 Redirected Autologous T Cells, covering 2017-10-17 to 2017-10-17. Get the full timeline:
Most recent: Clinical Trial Update: CD123 Redirected Autologous T Cells for AML [EARLY_Phase 1]